http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#Head http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#assertion http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#provenance http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#pubInfo http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#assertion http://purl.obolibrary.org/obo/MONDO_0004985 http://www.w3.org/1999/02/22-rdf-syntax-ns#type https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/MONDO_0004985 http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/DRUGBANK:DB00734 http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#association http://www.w3.org/2000/01/rdf-schema#label When we asked about the long-term treatment of BD, after having excluded from the analyses the 3 SGAs with a European indication for maintenance BD treatment (aripiprazole, olanzapine, and quetiapine), asenapine was considered either “highly appropriate” or “appropriate” by 44.6% of the respondents, while other off-label SGAs (clozapine, paliperidone, risperidone, ziprasidone) were mostly considered inappro- priate for maintenance bipolar treatment http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#association https://w3id.org/biolink/vocab/has_population_context http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#context http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#association https://w3id.org/biolink/vocab/publications https://pubmed.ncbi.nlm.nih.gov/31291215 http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/OffLabelIndication http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#context http://www.w3.org/1999/02/22-rdf-syntax-ns#type https://w3id.org/biolink/vocab/Cohort http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#context http://www.w3.org/2000/01/rdf-schema#label Adults https://identifiers.org/DRUGBANK:DB00734 http://www.w3.org/1999/02/22-rdf-syntax-ns#type https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#provenance http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#assertion http://www.w3.org/ns/prov#generatedAtTime 2021-08-17T13:35:51.063600 http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#pubInfo http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#sig http://purl.org/nanopub/x/hasSignature kYj+cgZGV/ADRMOPicQhPuGaPOBRQzx/40hrrPzYCmGFXxjw6XhltP1OA2m6zIgknurH4c3TDksrBEuSZ1QPaRmvGDAQCARvySmpxlzwNhCPIwc/RwbK9oft8lXooD+ZQcqBUJ2lE91ulLIwL1YjirBdKSmX6Oj0WDitzFzgAE8= http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU http://www.w3.org/ns/prov#generatedAtTime 2021-08-17T13:35:51.063600 http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY